These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 35807391)
1. Conversion of Natural Narciclasine to Its C-1 and C-6 Derivatives and Their Antitumor Activity Evaluation: Some Unusual Chemistry of Narciclasine. Goulart Stollmaier J; Thomson J; Endoma-Arias MA; Simionescu R; Vernaza A; Mesa-Diaz N; Smith M; Du L; Kornienko A; Hudlicky T Molecules; 2022 Jun; 27(13):. PubMed ID: 35807391 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. Ingrassia L; Lefranc F; Dewelle J; Pottier L; Mathieu V; Spiegl-Kreinecker S; Sauvage S; El Yazidi M; Dehoux M; Berger W; Van Quaquebeke E; Kiss R J Med Chem; 2009 Feb; 52(4):1100-14. PubMed ID: 19199649 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide. Vshyvenko S; Reisenauer MR; Rogelj S; Hudlicky T Bioorg Med Chem Lett; 2014 Sep; 24(17):4236-8. PubMed ID: 25108300 [TBL] [Abstract][Full Text] [Related]
4. Isolation, Synthesis, and Semisynthesis of Amaryllidaceae Constituents from Narcissus and Galanthus sp.: De Novo Total Synthesis of 2- epi-Narciclasine. Borra S; Lapinskaite R; Kempthorne C; Liscombe D; McNulty J; Hudlicky T J Nat Prod; 2018 Jun; 81(6):1451-1459. PubMed ID: 29787267 [TBL] [Abstract][Full Text] [Related]
5. Biological evaluation of ent-narciclasine, ent-lycoricidine, and certain enantiomerically-related congeners. Matveenko M; Banwell MG; Joffe M; Wan S; Fantino E Chem Biodivers; 2009 May; 6(5):685-91. PubMed ID: 19479847 [TBL] [Abstract][Full Text] [Related]
9. Total Synthesis of Lycoricidine and Narciclasine by Chemical Dearomatization of Bromobenzene. Southgate EH; Holycross DR; Sarlah D Angew Chem Int Ed Engl; 2017 Nov; 56(47):15049-15052. PubMed ID: 29024240 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives. Ghavre M; Froese J; Pour M; Hudlicky T Angew Chem Int Ed Engl; 2016 May; 55(19):5642-91. PubMed ID: 26969844 [TBL] [Abstract][Full Text] [Related]
12. Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives. Hudlicky T; Rinner U; Gonzalez D; Akgun H; Schilling S; Siengalewicz P; Martinot TA; Pettit GR J Org Chem; 2002 Dec; 67(25):8726-43. PubMed ID: 12467383 [TBL] [Abstract][Full Text] [Related]
13. Chemistry, biology, and medicinal potential of narciclasine and its congeners. Kornienko A; Evidente A Chem Rev; 2008 Jun; 108(6):1982-2014. PubMed ID: 18489166 [No Abstract] [Full Text] [Related]
14. Design and Synthesis of C-1 Methoxycarbonyl Derivative of Narciclasine and Its Biological Activity. Habaz L; Bedard K; Smith M; Du L; Kornienko A; Hudlicky T Molecules; 2022 Jun; 27(12):. PubMed ID: 35744934 [TBL] [Abstract][Full Text] [Related]
15. Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. Bräutigam J; Bischoff I; Schürmann C; Buchmann G; Epah J; Fuchs S; Heiss E; Brandes RP; Fürst R J Mol Cell Cardiol; 2019 Oct; 135():97-108. PubMed ID: 31381906 [TBL] [Abstract][Full Text] [Related]
16. Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice Follies. Pettit GR; Tan R; Bao GH; Melody N; Doubek DL; Gao S; Chapuis JC; Williams L J Nat Prod; 2012 Apr; 75(4):771-3. PubMed ID: 22413911 [TBL] [Abstract][Full Text] [Related]
17. A short route to enantiomerically pure benzophenanthridinone skeleton: synthesis of lactone analogues of narciclasine and lycoricidine. Ibn-Ahmed S; Khaldi M; Chrétien F; Chapleur Y J Org Chem; 2004 Oct; 69(20):6722-31. PubMed ID: 15387596 [TBL] [Abstract][Full Text] [Related]
18. Antineoplastic agents. 450. Synthesis of (+)-pancratistatin from (+)-narciclasine as relay(1a). Pettit GR; Melody N; Herald DL J Org Chem; 2001 Apr; 66(8):2583-7. PubMed ID: 11304174 [TBL] [Abstract][Full Text] [Related]
19. Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers. Van Goietsenoven G; Mathieu V; Lefranc F; Kornienko A; Evidente A; Kiss R Med Res Rev; 2013 Mar; 33(2):439-55. PubMed ID: 22419031 [TBL] [Abstract][Full Text] [Related]
20. Narciclasine suppresses esophageal cancer cell proliferation and migration by inhibiting the FAK signaling pathway. Qiu Y; Fang B; Thuy NTT; Li A; Yoo HM; Zheng X; Cho N Eur J Pharmacol; 2022 Apr; 921():174669. PubMed ID: 35248554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]